MedTrace Logo

Evaluation of Electrophysiological Signal Measured by Smart Textile CE-marked

NCT03725462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-07-09

No results posted yet for this study

Summary

The aim is to evaluate the performance of Cardioskin and Neuronaute, two connected medical devices CE-marked, manufactured by Bioserenity.

It's an open monocentric comparative clinical study, where subjects will test the Cardioskin device and/or the Neuronaute device.

Conditions

  • Healthy

Interventions

DEVICE

Cardioskin

Subjects have a monitoring with cardioskin and comparator

DEVICE

Neuronaute

Subjects have a monitoring with Neuronaute and comparator

Sponsors & Collaborators

  • BioSerenity

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-16
Primary Completion
2019-03-02
Completion
2019-04-16

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03725462 on ClinicalTrials.gov